STAT5A and STAT5B have opposite correlations with drug response gene expression

Area of Science:

• Molecular Biology
• Pharmacogenomics
• Gene Regulation

Background:

• Signal transducer and activator of transcription 5A (STAT5A) and STAT5B are homologous transcription factors with crucial roles in physiological processes.
• These factors regulate drug-metabolizing enzymes, particularly hepatic cytochrome P450s (CYPs), influencing drug response and gender-specific differences.
• While often functionally similar, STAT5A and STAT5B can exhibit distinct roles in gene expression regulation.

Purpose of the Study:

• To investigate the association between STAT5A and STAT5B mRNA expression levels and key hepatic cytochrome P450s (CYPs) and transcription factors (TFs).
• To evaluate the potential roles of STAT5A and STAT5B in mediating gender differences in the expression of these hepatic genes.
• To explore the distinct regulatory functions of STAT5A and STAT5B in the context of drug metabolism and response.

Main Methods:

• RNA sequencing (RNA-seq) was employed for expression profiling of major hepatic CYP isoforms and TFs in 102 human liver samples (57 female, 45 male).
• Real-time PCR was used to validate RNA-seq findings on a subset of 50 liver samples (25 female, 25 male).
• Statistical analyses were performed to assess correlations between STAT5A/STAT5B expression and CYP/TF expression, including gender-specific analyses.

Main Results:

• STAT5A showed significant negative correlations with multiple hepatic TFs (e.g., NR1I2, HNF4A) and drug-metabolizing enzymes (DMEs) like CYP3A4 and CYP2C19.
• STAT5B exhibited positive associations with several analyzed CYPs and TFs, suggesting distinct regulatory roles compared to STAT5A.
• Gender-dependent differential associations were observed between STAT5A/STAT5B and several CYPs/TFs, highlighting their role in sex-based variations in gene expression.

Conclusions:

• STAT5A and STAT5B possess distinct roles in regulating hepatic drug-metabolizing genes, evidenced by their opposing correlation patterns with CYP and TF expression.
• The findings suggest STAT5A negatively regulates, while STAT5B positively influences, the expression of key hepatic genes involved in drug metabolism.
• Further research is warranted to fully elucidate the specific mechanisms and clinical implications of STAT5A and STAT5B in regulating CYPs and TFs, particularly concerning gender differences.